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Fukushima Daiichi Nuclear Power Plant. A 14 m high tsunami
triggered by the earthquake disabled all AC power to Units 1, 2,
and 3 of the Power Plant, and carried off fuel tanks for emergency
diesel generators. Despite many efforts, cooling systems did not
work and hydrogen explosions damaged the facilities, releasing a
large amount of radioactive material into the environment. In this
review, we describe the environmental impact of the nuclear
accident, and the fundamental biological effects, acute and late,
of the radiation. Possible medical countermeasures to radiation
exposure are also discussed.
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Introduction On March 11, 2011, an earthquake and tsunami of unprece-
dented scale led to major problems with the stabilization of
nuclear power plants (NPP) in northeastern Japan. Operating reac-
tors shut down automatically, with control rods inserting into the
reactor cores. However, the 14-meter tsunami triggered by the
earthquake disabled all AC power to Units 1, 2, and 3 of the
Fukushima Daiichi Power Plant, carrying away fuel tanks for
emergency diesel generators. Water injection failed in the emer-
gency core cooling system of Units 1, 2, and 3. Since the normal
cooling system was inoperable, a pressure valve was opened
manually to reduce the pressure in the reactor container. In spite of
such efforts, hydrogen explosions damaged the facilities. Eventu-
ally, a large amount of radioactive material was released into the
environment.
The Environmental Impact of the Nuclear Accident at
Tokyo Electric Power Company (TEPCO) Fukushima
Daiichi Nuclear Power Plant
This chapter provides an overview of the accident and the
activities of Hirosaki University in Fukushima.
Sequence of events at Fukushima Daiichi. Table 1 demon-
strates the Fukushima Daiichi event sequence from March 11 to
15.(1) It was derived from information collected by Japan’s
national nuclear regulator, the Nuclear and Industrial Safety
Agency.
Activities of Hirosaki University. On March 13, members
of the Radiation Safety Council at Hirosaki University convened a
meeting to discuss responses to this accident.(2) At the request of
the Japanese government, the council decided to dispatch univer-
sity staff members to Fukushima to support the people living
there. The first team was sent on March 15.
The teams had two major functions. The first was to perform
screening tests for radioactive contamination among the general
public in Fukushima Prefecture. The second was to assist with
temporary visits by evacuees to the homes in a 20-km zone.
Radiation measurements and sampling were also conducted.
Screening tests for radioactive contamination. Twenty 
teams consisting of a radiation expert, a nurse and a clerk were
dispatched to Fukushima by the end of July. Some 82 people were
involved from the university. More than 5,000 people were
examined. A GM survey meter (e.g. TGS-146B, Aloka, Co., Japan)
was used for screening. Fig. 1 illustrates a screening test carried
out by a university staff member. A count exceeding 100,000 cpm
was regarded as indicative of radioactive contamination, requiring
decontamination. A decontamination room was prepared by the
Self-Defence Forces. For a count of between 13,000 and
100,000 cpm, decontamination was advised. If the count was less
than 13,000 cpm, no decontamination was needed.
Temporary visits by evacuees to homes in a 20 km zone.
To support temporary visits, 11 teams consisting of a medical
doctor, a nurse, a radiation expert and a clerk, were dispatched to
Fukushima from late May through early August. Some 51 people
were involved from the university.
Radiation measurements in the field. Dose rates in air
along an expressway passing northwest of the Fukushima Daiichi
NPP were measured in a car-borne survey.(3) Car-borne surveys
are commonly used for the rapid assessment of dose rates in
emergency situations. The measurements were conducted 3 times:
on March 16, April 11 and April 25, 2011. The distance between
the Fukushima NPP and measurement points ranged from 60 to
355 km, and the typical distance between measurements points
was approximately 3 km. Total distance on the expressway was
about 1,256 km. A 1'' × 1'' NaI (Tl) scintillation survey meter
(TCS-171, ALOKA Co., Japan) was used, and measurements
were carried out every minute. The meter was calibrated with a
2'' × 2'' NaI (Tl) scintillation spectrometer (SPA-3, Eberline Co.,
New Mexico). Latitude and longitude at each measurement point
were measured using a global positioning system (WPL-2000,
Wintec Co., Ltd., Taiwan). More than 100 measurements were
obtained in each survey. Shielding by the car body was estimated
by making measurements inside and outside of the car at 56 points.
A shielding factor of 1.9 ± 0.04 was used.
Fig. 2 shows the temporal variation of dose rates in air before
and after the start of the Fukushima NPP crisis. In the first survey,
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dose rates along the expressway between Fukushima City and
Osaki City were found to have increased markedly, from about
0.08 to up to 11 μGy h-1. In the remaining part of the transect,
however, the dose rates increased little, by a factor of about 1.5 to
2.5. In the second and third surveys, the dose rate profile along the
transect looked quite different. The effect was particularly striking
around Oshu City, where the dose rate increased by a factor of up
to 10 between the first and the second surveys.
Early Stages of Biological Effects of Radiation and Radia 
tion Damage
On exposure to ionizing radiation, water, which is makes up
more than 60% of the body, is ionized generating reactive oxygen
species (ROS), such as hydrated electron (eaq−) and hydrogen
radical (￿H).(4) These mayors can react withother substances in the
body to initiate damage. This type of effect on living organisms is
indirect. On the other hand, radiation can also directly inactivate
substances in the body. Actually, both the direct and indirect
Table 1. Fukushima Daiichi event sequence (March 11 through 15)
Date Time Events
March 11 2:46 p.m. A 9.0 magnitude earthquake strikes. Ground acceleration triggers automatic shutdown of all three reactors in 
operation.
3:42 p.m. A 14 meter tsunami triggered by the earthquake disables all AC power to Units 1, 2 and 3.
3:45 p.m. Fuel tanks for emergency diesel generators are carried off by the tsunami.
4:46 p.m. Water injection fails in the emergency core cooling systems of Units 1 and 2.
March 12 9:07 p.m. A pressure relief valve is opened on the Unit 1 pressure vessel.
3:36 p.m. A hydrogen explosion damages the structure of the Unit 1 reactor building.
8:20 p.m. Seawater injection to the Unit 1 pressure vessel begins.
5:58 a.m. Water injection fails in the emergency core cooling system of Unit 3.
March 13 9:20 a.m. A pressure relief valve is opened on the Unit 3 pressure vessel.
4:46 p.m. Water injection fails in the emergency core cooling systems of Unit 1 and 2.
11:01 a.m. A hydrogen explosion damages the external structure of the Unit 3 reactor building.
March 14 1:25 p.m. The water level in the Unit 2 pressure vessel is found to be low, leading operators to conclude that the reactor 
cooling system is no longer functional.
4:34 p.m. Seawater injection into the Unit 2 pressure vessel begins.
6:20 a.m. An explosion sound is heard at Unit 2 and it concluded to indicate an abnormality in the pressure suppression 
pool. At the same time, part of a wall in the operation area of Unit 4 is damaged.
9:38 a.m. A fire breaks out in the Unit 4 reactor building.
March 15 12:29 p.m. The unit 4 fire is extinguished.
Fig. 1. Screening test carried out by Hirosaki University staff.
Fig. 2. Expressway survey route for measuring dose rates in air from
Hirosaki City to Fukushima City. Temporal variation of dose rates in air
before and after the start of the Fukushima NPS crisis.
Reprinted by permission from Macmillan Publishers Ltd. Scientific Reports
1, Article number 87, Figure 1, 7 September 2011, online only, copyright
2011.doi: 10.3164/jcbn.D 11 00021
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effects of radiation cause biological damage. However, the
difference is due to the type of radiation and physical and/or
chemical conditions. Modulatory action can be explained by
indirect effects.
As for the biological effects of radiation, damage such as cancer
is mainly considered. When living organisms are exposed to
radiation, the main effects are divided into early, intermediate and
late as shown in Fig. 3.(5) Although the three cannot be completely
distinguished, the generation of ROS occurs between the early and
intermediate stages and the influence of ROS should appear in the
late stage.
H2O → H2O+ + eaq− (1)
The cation (H2O+) thus formed may give the hydroxyl radical
(￿OH) as follows:
H2O+ → H+ + ￿OH (2)
The ￿H is generated from the reaction of hydrated ion with a water
molecule as follows:
eaq− + H2O → OH− + ￿H (3)
Except for these simple reactions, the direct dissociation of an
excited (about 7 eV) water molecule may generate ￿H and ￿OH as
follows:
H2O → H2O* → ￿H + ￿OH (* shows an excited state) (4)
Table 2 shows G values of radiation with low ionized density at
pH 3–10.(6)
Further, molecular oxygen usually exists in living cells, and
then, eaq− or ￿H generated from the radiolysis of water reacts with
molecular oxygen (O2) to yield superoxide ion (O2￿−) or its conju-
gated acid, the hydroperoxyl radical (HO2￿) as follows:
eaq− + O2 → O2￿− (5)
￿H + O2 → HO2￿ (6)
HO2￿ ←→  H+ + O2￿− (7)
(pKa = 4.5–4.9)(7)
Thus, the damage to living organisms from the indirect effects
of radiation may be caused by the reactive species mentioned
above. The effect of radiation is strengthened by the formation of
many kinds of ROS and free radicals due to the existence of water
Fig. 3. Time dependent process of biological effects after exposure of radiation.
Table 2. Yield of primary products generated from radiolysis of water
Product G value
eaq− 2.7
￿H 0.55
￿OH 2.7
H2 0.45
H2O2 0.7
H2O+ 2.7 J. Clin. Biochem. Nutr. | January 2012 | vol. 50 | no. 1 | 5
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in the living body. This “oxygen effect” is 2.5–3 times that in the
absence.
As for radiation damage, those reactive species mentioned
above can react with DNA either directly or after metal-catalyzed
transformation in the cell. As many as 100 different DNA modifi-
cations have been identified after exposure to ionizing radiation.(4)
These include single- and double-strand breaks, base modifica-
tions, abasic sites and cross-links. These lesions are primary sites
for radiation-induced cell lethality, mutations and malignant
transformation. The double-strand breaks in DNA are particularly
important to the lethal effect of ionizing radiation. However, the
biological importance of base modifications has not been clearly
established.
There are two types of radiation injuries, acute radiation injury
and delayed radiation injury. Both types are observed in many
radiation accidents.
Acute radiation injury. When whole-body is exposed to
high-dose radiation, many types of damage occur depending on
the radiation-exposed dose. Such damage is known as acute
radiation injury. Table 3 summarizes the effect on living organisms
of exposure to ionizing radiation.
Late radiation injury. When whole-body is exposed to low-
dose radiation or repeatedly exposed to low dose-rate radiation,
some effects appear over a period of years or decades. Such
damage is known as delayed radiation injury. Among them, radia-
tion carcinogenesis, such as leukemia and other malignancies, is
thought to have no threshold dose and is classified as a stochastic
effect. Cataracts are also a form of late radiation injury, but have a
threshold dose for onset and are classified as deterministic effects.
Health Effects of Radiation at Low Doses
DNA damage and health effects. DNA is deemed the most
important target of radiation leading to effects on health. Ionizing
radiation causes several types of DNA damage directly or indi-
rectly. While the repair machinery in the cell processes the
damage, some areas could remain unrepaired or be misrepaired.
When unrepaired/misrepaired damage unduly accumulates in a
cell, or when the damage results in a lethal mutation, the cell
deteriorates and dies. This can manifest as impaired organ func-
tion and a destruction of tissue structure. This kind of effect is
called an adverse tissue reaction or deterministic effect. If the
fraction of deteriorated/dead cells in the tissue remains small, no
symptoms will become clinically evident since the defects are
compensated for by the large majority of normal cells. Hence,
adverse tissue reactions appear at doses above a certain threshold,
and follow the dose response illustrated in Fig. 4A. The threshold
value differs among tissues. The most sensitive organ is the testis
with a threshold dose of 100 mGy for temporary infertility. An
embryo is also sensitive, and malformation could be induced at
doses above 100 mGy during the period of major organogenesis.(8)
In the Fukushima accident, no one seems to have been exposed
to doses above any threshold for tissue reactions, and this type of
effect is not an issue.
Misrepaired DNA damage is not always lethal to cells. The
resultant mutation is often compatible with cell viability. Although
most viable mutated cells are thought to have little or no influence
on health, some could contribute to malignant transformation.
Germ cells could also carry critical mutations that result in
heritable diseases in later generations. Given that cancers and
heritable effects arise from a single mutated cell, their incidence
is thought to increase with dose with no threshold as shown in
Fig. 4B. The cancerous and heritable effects of radiation are
collectively called stochastic effects.
Epidemiological evidence. A dose-dependent increase of
cancer in rates has been demonstrated by epidemiological studies.
Among them, the study of atomic-bomb survivors of Hiroshima
and Nagasaki is regarded as the most powerful and reliable. A
recent report indicated that the excess relative risk (ERR) of solid
cancer increases linearly with dose up to 2 Gy, and the gender-
averaged estimate of ERR per Gy is 0.47 for a person aged 70
exposed to the bombings at age 30.(9) It should be noted the
increase is not statistically significant at doses below ~150 mGy.
Some case-control studies, particularly what is known as the
Oxford survey, suggest excess risk of childhood cancer associated
with lower levels of exposure, a few tens of mGy.(10) The inter-
pretation of these studies is controversial, however, since compa-
rable excess has not been identified in any cohort study.
In the case of internal exposure, there is considerable uncer-
tainty in estimating dose and risk. Nevertheless epidemiological
studies for internal emitters suggest that the risk per unit dose is
not remarkably high in comparison with external exposure, based
on the current internal dose assessment system.(11) There is an
argument that precancerous lesions of the urinary bladder were
induced in the Ukrainian population by very low levels of internal
exposure to 137Cs.(12) However, the claim is quite unlikely since
the bladder doses of those subjects from 137Cs are estimated to be
much lower than the doses from natural 40K. The proposed
association between precancerous lesions and internal 137Cs can be
attributed to selection bias and confounding factors.
Unlike for cancer, there is no epidemiological evidence for the
induction of heritable effects.(8) Offspring of a-bomb survivors,
radiologists, and those living in areas of high background radiation
have been studied, but no indication of trans-generational effects
of radiation has been found. This may be because radiation-
induced mutations are often deletions of a large DNA segment
that are incompatible with live birth. Although the possibility of
Table 3. Doses and effects on exposure to ionizing radiation
Dose (mSv) Effect
0.1–0.3 chest X ray
3–4 world average dose per year of exposure to radiation
0.6–2.7 stomach radiography
7–20 CT scan
50 dose limit per year among radiation workers
200 lifetime exposure to natural radiation
500 decrease in lymphocytes, cataracts
1000 acute radiation damage, nausea, vomiting
2000 5% of those exposed die within several weeks
3000–5000 50% of those exposed die within several weeks
7000–10000 95% of those exposed die within several weeks
20000–60000 cerebral edema, respiratory distress, diarrhea, fever, 
circulatory failure within 1–2 weeks
100000 instant coma, death within hours
Fig. 4. Dose response for the health effects of radiation. A: Adverse
tissue reactions (deterministic effects). B: Cancer and heritable effects
(stochastic effects).doi: 10.3164/jcbn.D 11 00021
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heritable effects can not be ruled out, the epidemiological data
suggest the risk is small in comparison with the risk of cancer.
Biological features of low dose tumorigenesis. The bio-
logical mechanism of radiation tumorigenesis has been studied
intensively because of major concern about low dose effects.
Among various types of radiation-induced DNA damage, double-
strand breaks (DSBs) are believed to be a source of chromosomal
aberrations and somatic cell mutations that are responsible for
tumorigenesis. There are two major pathways for DSB repair,
nonhomologous end joining (NHEJ) and homologous recombina-
tion (HR).(13) While HR is a high fidelity process, a perfectly
matching sequence required for repair is available only in the late
S to G2 phase of the cell cycle. Consequently, most DSBs are
processed by NHEJ. A significant proportion of the DSBs caused
by radiation is associated with other closely spaced lesions,
creating clustered damage.(14) For this type of damage, the broken
ends will require additional processing prior to ligation, which
may result in a loss of base pairs. Moreover a complex form of
clustered damage that involves two or more DSBs can compro-
mise the fidelity of NHEJ, increasing the chances of misre-
joining.(15) Considering that even a single electron track traversing
a cell nucleus can induce clustered DNA damage, chromosome/
gene alterations would be inevitable however small the dose may
be. In fact a large-scale analysis of chromosomal aberrations in
human lymphocytes demonstrated a linear dose response down to
20 mGy.(16)
While the nature of radiation-induced DNA damage as well as
imperfect repair forms a strong basis for the linear non-threshold
(LNT) dose response for cancer induction, things may change
when higher order protective functions are taken into account.
Misrepaired, mutated cells could be eliminated by apoptosis, cell
competition, and immunological surveillance. If such protective
functions work more efficiently at lower doses, the dose-response
would be non-linear, and there might be a threshold. Furthermore,
some phenomena mainly found in cultured cells could possibly
complicate the situation, including adaptive responses in cells pre-
exposed to a low dose of radiation, bystander effects in cells that
are not directly irradiated, and genomic instability that manifests
in the progeny of irradiated cells many generations after exposure.
Currently it is unclear to what extent these three phenomena are
active in vivo, and how they are inter-related.(17)
Risk of radiation induced cancer. Summing up the epide-
miological data and biological findings, we are still unsure about
the shape of the dose response curve in the low dose range. While
several dose response curves are possible as illustrated in Fig. 5,
the LNT model is usually adopted as a best estimate for low dose
risk. Based on this model, the lifetime cancer risk per unit dose is
estimated to average ~5%/Sv over the whole population.(8) This
means cancer mortality will be 20.5% if all members are exposed
to 100 mSv of radiation, on the assumption of a background
cancer mortality rate of 20%. The value should not be interpreted
as a certain prediction, but an estimate with uncertainty.
In theory there is a possibility of cancer among people exposed
in the accident at the Fukushima Daiichi NPP. Assuming the LNT
model represents the reality of radiation-induced cancer at low
doses, however, significant excess risk due to exposure is unlikely
to be detected for the emergency workers and the public living
around the site unless their doses have been seriously under-
estimated.(18) This notion would be supported by the absence of
clear findings for the Chernobyl liquidators or residents in high
background radiation areas.(19,20) In this context, accident-related
epidemiological studies should place more focus on the effects of
anxiety, distress, and resulting changes in lifestyle factors rather
than exposure.
Possible Medical Countermeasures to Exposure
There are several ways to countermeasure exposure to radia-
tion. One is to use medicines to prevent or reduce radiation-
induced injuries. Such agents can be classified into two groups,
absorbents and radiation modifiers. People can be exposed
internally to radionuclides by ingesting or inhaling them, or
through direct contact. Absorbents protect agaist internal exposure
by preventing the accumulation or accelerating the exclusion of
radionuclides. Iodine tablets (stable potassium iodide) can be
used to prevent the absorption of radioactive iodine such as 131I in
the thyroid gland (http://www.bt.cdc.gov/radiation/ki.asp). Prussian
blue can be used to remove 137Cs from the human body by binding
to  137Cs. (http://emergency.cdc.gov/radiation/prussianblue.asp).
Diethylene-triamine-pentaacetic acid (DTPA) is expected to
chelate plutonium, removing it through the kidneys (http://
emergency.cdc.gov/radiation/dtpa.asp). Since such chemicals
have been stocked for possible use after nuclear accidents and a
certain amount of 131I was released by the Fukushima accident,
iodine tablets were used by workers at the contaminated site as a
preventive measure. The tablets were not delivered to people
living around the power plant (http://ajw.asahi.com/article/
0311disaster/fukushima/AJ201108298140).
Radiation modifiers may be used to prevent or reduce injuries
by modifying chemical/biological responses to radiation in the
living body.(21) One can classify compounds that ameliorate
radiation injuries into three categories with respect to the timing of
administration: compounds for the prophylaxis, mitigation, and
treatment of radiation injuries (Fig. 6). As shown above, since the
first event caused by ionizing radiation is the formation of free
radicals from water existing in the living body, major damage is
caused by aqueous free radicals. Therefore, compounds that
quench or scavenge free radicals should be effective at reducing
radiation damage. Most of the radiation modifiers reported to date
are protectors, used for prophylaxis, and should be present in the
appropriate position in the living body before exposure. In
contrast, to counteract accidental overexposure, it is necessary to
use compounds that are effective when administered after exposure.
These compounds are called mitigators and the relatively few
agents reported so far include LC9018,(22) tocopherol-mono-
glucoside (TMG),(23,24) mineral yeast,(25) and CBLB502.(26)
Only amifostine has been approved by the U.S. Food and
Drug Administration (FDA) for use as a protector in limited cases
of radiotherapy (http://www.drugs.com/pro/amifostine.html).
However, the toxicity of amifostine is not negligible. Regardless
of whether an agent is a protector or mitigator, it should have low
toxicity even if the radiation modifying activity is not very high, if
it is to be uses on large numbers of people. Therefore, chemicals
existing in the body or natural products that have been used for a
long time are possible candidates for radiation modifiers for
civilian populations.
Melatonin (N-acetyl-5-methoxytryptamine) is one such com-
pound. Melatonin is a naturally occurring compound found in
animals, plants, and microbes. In animals, it is a pineal hormone
and circulating levels of it vary in a daily cycle producing circa-
Fig. 5. Possible dose response curves for cancer induction at low doses.
A: supralinear, B: LNT (linear non threshold), C: threshold, D: hormetic. J. Clin. Biochem. Nutr. | January 2012 | vol. 50 | no. 1 | 7
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dian rhythms. Melatonin has reportedly radioprotective features
in both animal and human studies.(27–32) Because of its very low
toxicity, high availability, and ease of self-administration, some
leading researchers of melatonin claim that it may be useful in
providing protection against ionizing radiation in disasters like the
one at Fukushima.(33,34)
Another type of compound is natural antioxidants. Although
many compounds, especially from plants, have been studied as
radiation protectors in the laboratory, their effectiveness is
relatively low. Based on the antioxidant activity of hydrogen,(35)
water containing a high concentration of hydrogen was recently
reported to be a radiation protector.(36–39) It may become a new type
of radiation modifier with low toxicity.
In the Fukushima accident, no acute radiation injuries have been
observed even among people associated with the operation of the
plant or responding to the accident in contrast to the Chernobyl
accident where a number of people suffered acute radiation
injuries. The anxiety among most of the civilian population is the
future increase in the possibility of tumorigenesis. For high dose
exposure, some compounds have been reported to reduce specific
tumorigenesis. For example, curcumin, a component of turmeric,
reportedly reduced the rate of breast cancer in female rats
irradiated while lactating.(40) However, compounds effective at
reducing the probability of tumorigenesis caused by low-dose
exposure have not been reported as far as we know. As stated in
chapter III, in vivo low dose tumorigenesis is still a matter of
controversy. Animal experiments are needed but numerous
animals must be used to achieve significance because of the very
low probability of an event and very long time needed to observe
an end point. This must be overcome in the future.
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DSBs double-strand breaks
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